Effective radiotherapeutic treatment intensification in patients with pancreatic cancer: higher doses alone, higher RBE or both?

Abstract Pancreatic cancer, especially in case of locally advanced stage has a poor prognosis. Radiotherapy in general can lead to tumor volume reduction, but further improvements, such as ion beam therapy have to be promoted in order to enable dose escalation, which in turn results in better local...

Full description

Bibliographic Details
Main Authors: Constantin Dreher, Daniel Habermehl, Oliver Jäkel, Stephanie E. Combs
Format: Article
Language:English
Published: BMC 2017-12-01
Series:Radiation Oncology
Subjects:
RBE
Online Access:http://link.springer.com/article/10.1186/s13014-017-0945-2
id doaj-70dcbf4dce7c45fb8d8f09c4346d352e
record_format Article
spelling doaj-70dcbf4dce7c45fb8d8f09c4346d352e2020-11-25T00:04:50ZengBMCRadiation Oncology1748-717X2017-12-011211810.1186/s13014-017-0945-2Effective radiotherapeutic treatment intensification in patients with pancreatic cancer: higher doses alone, higher RBE or both?Constantin Dreher0Daniel Habermehl1Oliver Jäkel2Stephanie E. Combs3Department of Radiation Oncology, University Hospital Rechts der Isar, Technical University Munich (TUM)Department of Radiation Oncology, University Hospital Rechts der Isar, Technical University Munich (TUM)Department of Medical Physics in Radiation Oncology, German Cancer Research CenterDepartment of Radiation Oncology, University Hospital Rechts der Isar, Technical University Munich (TUM)Abstract Pancreatic cancer, especially in case of locally advanced stage has a poor prognosis. Radiotherapy in general can lead to tumor volume reduction, but further improvements, such as ion beam therapy have to be promoted in order to enable dose escalation, which in turn results in better local control rates and downsizing of the tumor itself. Ion beam therapy with its highly promising physical properties is also accompanied by distinct inter- and intrafractional challenges in case of robustness. First clinical results are promising, but further research in motion mitigation and biological treatment planning is necessary, in order to determine the best clinical rationales and conditions of ion beam therapy of pancreatic cancer. This review summarizes the current knowledge and studies on ion beam therapy of pancreatic cancer.http://link.springer.com/article/10.1186/s13014-017-0945-2Pancreatic cancerRBEIon beam therapyProtonsCarbon ionsParticle radiotherapy
collection DOAJ
language English
format Article
sources DOAJ
author Constantin Dreher
Daniel Habermehl
Oliver Jäkel
Stephanie E. Combs
spellingShingle Constantin Dreher
Daniel Habermehl
Oliver Jäkel
Stephanie E. Combs
Effective radiotherapeutic treatment intensification in patients with pancreatic cancer: higher doses alone, higher RBE or both?
Radiation Oncology
Pancreatic cancer
RBE
Ion beam therapy
Protons
Carbon ions
Particle radiotherapy
author_facet Constantin Dreher
Daniel Habermehl
Oliver Jäkel
Stephanie E. Combs
author_sort Constantin Dreher
title Effective radiotherapeutic treatment intensification in patients with pancreatic cancer: higher doses alone, higher RBE or both?
title_short Effective radiotherapeutic treatment intensification in patients with pancreatic cancer: higher doses alone, higher RBE or both?
title_full Effective radiotherapeutic treatment intensification in patients with pancreatic cancer: higher doses alone, higher RBE or both?
title_fullStr Effective radiotherapeutic treatment intensification in patients with pancreatic cancer: higher doses alone, higher RBE or both?
title_full_unstemmed Effective radiotherapeutic treatment intensification in patients with pancreatic cancer: higher doses alone, higher RBE or both?
title_sort effective radiotherapeutic treatment intensification in patients with pancreatic cancer: higher doses alone, higher rbe or both?
publisher BMC
series Radiation Oncology
issn 1748-717X
publishDate 2017-12-01
description Abstract Pancreatic cancer, especially in case of locally advanced stage has a poor prognosis. Radiotherapy in general can lead to tumor volume reduction, but further improvements, such as ion beam therapy have to be promoted in order to enable dose escalation, which in turn results in better local control rates and downsizing of the tumor itself. Ion beam therapy with its highly promising physical properties is also accompanied by distinct inter- and intrafractional challenges in case of robustness. First clinical results are promising, but further research in motion mitigation and biological treatment planning is necessary, in order to determine the best clinical rationales and conditions of ion beam therapy of pancreatic cancer. This review summarizes the current knowledge and studies on ion beam therapy of pancreatic cancer.
topic Pancreatic cancer
RBE
Ion beam therapy
Protons
Carbon ions
Particle radiotherapy
url http://link.springer.com/article/10.1186/s13014-017-0945-2
work_keys_str_mv AT constantindreher effectiveradiotherapeutictreatmentintensificationinpatientswithpancreaticcancerhigherdosesalonehigherrbeorboth
AT danielhabermehl effectiveradiotherapeutictreatmentintensificationinpatientswithpancreaticcancerhigherdosesalonehigherrbeorboth
AT oliverjakel effectiveradiotherapeutictreatmentintensificationinpatientswithpancreaticcancerhigherdosesalonehigherrbeorboth
AT stephanieecombs effectiveradiotherapeutictreatmentintensificationinpatientswithpancreaticcancerhigherdosesalonehigherrbeorboth
_version_ 1725427805051682816